Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions

This article summarizes the current literature and documents new evidence concerning drug-drug interactions (DDI) stemming from pharmacogenomic and circadian rhythm determinants of therapies used to treat common cardiovascular diseases (CVD), such as atherosclerosis and hypertension. Patients with C...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Yong-Jian, Madonna, Rosalinda, Hermida, Ramon C., Smolensky, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Pharmacology and Drug Interactions Edited by Dr. Luigino Calzetta and Dr. Cynthia Koziol-White
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663962/
https://www.ncbi.nlm.nih.gov/pubmed/34909660
http://dx.doi.org/10.1016/j.crphar.2021.100025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663962/
https://www.ncbi.nlm.nih.gov/pubmed/34909660
http://dx.doi.org/10.1016/j.crphar.2021.100025

Ejemplares similares